These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 20048692)

  • 1. First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation.
    Di Benedetto F; Di Sandro S; De Ruvo N; Montalti R; Ballarin R; Guerrini GP; Spaggiari M; Guaraldi G; Gerunda G
    Transplantation; 2010 Mar; 89(6):733-8. PubMed ID: 20048692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. University of Modena experience in HIV-positive patients undergoing liver transplantation.
    Di Benedetto F; Tarantino G; De Ruvo N; Cautero N; Montalti R; Guerrini GP; Ballarin R; Spaggiari M; Smerieri N; Serra V; Rompianesi G; D'Amico G; Mimmo A; Iemmolo RM; Codeluppi M; Cocchi S; Guaraldi G; Gerunda GE
    Transplant Proc; 2011 May; 43(4):1114-8. PubMed ID: 21620066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus and liver transplantation: our point of view.
    Di Benedetto F; Di Sandro S; De Ruvo N; Berretta M; Montalti R; Guerrini GP; Ballarin R; De Blasiis MG; Spaggiari M; Smerieri N; Iemmolo RM; Guaraldi G; Gerunda GE
    Transplant Proc; 2008; 40(6):1965-71. PubMed ID: 18675102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection.
    Norris S; Taylor C; Muiesan P; Portmann BC; Knisely AS; Bowles M; Rela M; Heaton N; O'Grady JG
    Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
    Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
    Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation in HIV/hepatitis co-infection.
    Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
    J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.
    Duclos-Vallée JC; Vittecoq D; Teicher E; Feray C; Roque-Afonso AM; Lombès A; Jardel C; Gigou M; Dussaix E; Sebagh M; Guettier C; Azoulay D; Adam R; Ichaï P; Saliba F; Roche B; Castaing D; Bismuth H; Samuel D
    J Hepatol; 2005 Mar; 42(3):341-9. PubMed ID: 15710216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
    Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study.
    Gutiérrez-Moreno M; Bernal-Bellido C; Suárez-Artacho G; Alamo-Martínez JM; Marín-Gómez LM; Serrano-Díaz-Canedo J; Padillo-Ruiz FJ; Gómez-Bravo MA
    Transplant Proc; 2012 Sep; 44(7):2100-2. PubMed ID: 22974923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of human immunodeficiency virus-infected liver transplant recipients.
    Ragni MV; Belle SH; Im K; Neff G; Roland M; Stock P; Heaton N; Humar A; Fung JF
    J Infect Dis; 2003 Nov; 188(10):1412-20. PubMed ID: 14624365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Gonzalez-Koch A; Maor-Kendler Y; Batts K; Moreno-Luna L; Poterucha J; Burgart L; Wiesner R; Kremers W; Rosen C; Charlton MR
    Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E
    AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal transplantation in HIV-infected patients in Spain].
    Mazuecos A; Pascual J; Gómez E; Sola E; Cofán F; López F; Puig-Hooper CE; Baltar JM; González-Molina M; Oppenheimer F; Marcén R; Rivero M
    Nefrologia; 2006; 26(1):113-20. PubMed ID: 16649432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.